Cargando…
Circulating Total Bilirubin and Future Risk of Hypertension in the General Population: The Prevention of Renal and Vascular End‐Stage Disease (PREVEND) Prospective Study and a Mendelian Randomization Approach
BACKGROUND: Circulating total bilirubin is known to be inversely and independently associated with future risk of cardiovascular disease. However, the relationship of circulating total bilirubin with incident hypertension is uncertain. We aimed to assess the association of total bilirubin with futur...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721749/ https://www.ncbi.nlm.nih.gov/pubmed/29133521 http://dx.doi.org/10.1161/JAHA.117.006503 |
_version_ | 1783284872289189888 |
---|---|
author | Kunutsor, Setor K. Kieneker, Lyanne M. Burgess, Stephen Bakker, Stephan J.L. Dullaart, Robin P.F. |
author_facet | Kunutsor, Setor K. Kieneker, Lyanne M. Burgess, Stephen Bakker, Stephan J.L. Dullaart, Robin P.F. |
author_sort | Kunutsor, Setor K. |
collection | PubMed |
description | BACKGROUND: Circulating total bilirubin is known to be inversely and independently associated with future risk of cardiovascular disease. However, the relationship of circulating total bilirubin with incident hypertension is uncertain. We aimed to assess the association of total bilirubin with future hypertension risk and supplemented this with a Mendelian randomization approach to investigate any causal relevance to the association. METHODS AND RESULTS: Plasma total bilirubin levels were measured at baseline in the PREVEND (Prevention of Renal and Vascular End‐Stage Disease) prospective study of 3989 men and women without hypertension. Hazard ratios (95% confidence intervals) of total bilirubin with incident hypertension were assessed. New‐onset hypertension was recorded in 1206 participants during a median follow‐up of 10.7 years. Baseline total bilirubin was approximately log‐linearly associated with hypertension risk. Age‐ and sex‐adjusted hazard ratio for hypertension per 1‐SD increase in log(e) total bilirubin was 0.86 (0.81–0.92; P<0.001), which was attenuated to 0.94 (0.88–0.99; P=0.040) after further adjustment for established risk factors and other potential confounders. The association was marginally significant on further adjustment for high‐sensitivity C‐reactive protein (0.94; 0.88–1.00; P=0.067). A genetic variant at the UGT1A1*28 locus consistently shown to be strongly associated with circulating bilirubin levels—rs6742078—was not significantly associated with blood pressure or hypertension (P>0.05 for all), arguing against a strong causal association of circulating bilirubin with blood pressure. CONCLUSIONS: The weak and inverse association of circulating total bilirubin with future hypertension risk may be driven by biases such as unmeasured confounding and/or reverse causation. Further evaluation is warranted. |
format | Online Article Text |
id | pubmed-5721749 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-57217492017-12-12 Circulating Total Bilirubin and Future Risk of Hypertension in the General Population: The Prevention of Renal and Vascular End‐Stage Disease (PREVEND) Prospective Study and a Mendelian Randomization Approach Kunutsor, Setor K. Kieneker, Lyanne M. Burgess, Stephen Bakker, Stephan J.L. Dullaart, Robin P.F. J Am Heart Assoc Original Research BACKGROUND: Circulating total bilirubin is known to be inversely and independently associated with future risk of cardiovascular disease. However, the relationship of circulating total bilirubin with incident hypertension is uncertain. We aimed to assess the association of total bilirubin with future hypertension risk and supplemented this with a Mendelian randomization approach to investigate any causal relevance to the association. METHODS AND RESULTS: Plasma total bilirubin levels were measured at baseline in the PREVEND (Prevention of Renal and Vascular End‐Stage Disease) prospective study of 3989 men and women without hypertension. Hazard ratios (95% confidence intervals) of total bilirubin with incident hypertension were assessed. New‐onset hypertension was recorded in 1206 participants during a median follow‐up of 10.7 years. Baseline total bilirubin was approximately log‐linearly associated with hypertension risk. Age‐ and sex‐adjusted hazard ratio for hypertension per 1‐SD increase in log(e) total bilirubin was 0.86 (0.81–0.92; P<0.001), which was attenuated to 0.94 (0.88–0.99; P=0.040) after further adjustment for established risk factors and other potential confounders. The association was marginally significant on further adjustment for high‐sensitivity C‐reactive protein (0.94; 0.88–1.00; P=0.067). A genetic variant at the UGT1A1*28 locus consistently shown to be strongly associated with circulating bilirubin levels—rs6742078—was not significantly associated with blood pressure or hypertension (P>0.05 for all), arguing against a strong causal association of circulating bilirubin with blood pressure. CONCLUSIONS: The weak and inverse association of circulating total bilirubin with future hypertension risk may be driven by biases such as unmeasured confounding and/or reverse causation. Further evaluation is warranted. John Wiley and Sons Inc. 2017-11-13 /pmc/articles/PMC5721749/ /pubmed/29133521 http://dx.doi.org/10.1161/JAHA.117.006503 Text en © 2017 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Original Research Kunutsor, Setor K. Kieneker, Lyanne M. Burgess, Stephen Bakker, Stephan J.L. Dullaart, Robin P.F. Circulating Total Bilirubin and Future Risk of Hypertension in the General Population: The Prevention of Renal and Vascular End‐Stage Disease (PREVEND) Prospective Study and a Mendelian Randomization Approach |
title | Circulating Total Bilirubin and Future Risk of Hypertension in the General Population: The Prevention of Renal and Vascular End‐Stage Disease (PREVEND) Prospective Study and a Mendelian Randomization Approach |
title_full | Circulating Total Bilirubin and Future Risk of Hypertension in the General Population: The Prevention of Renal and Vascular End‐Stage Disease (PREVEND) Prospective Study and a Mendelian Randomization Approach |
title_fullStr | Circulating Total Bilirubin and Future Risk of Hypertension in the General Population: The Prevention of Renal and Vascular End‐Stage Disease (PREVEND) Prospective Study and a Mendelian Randomization Approach |
title_full_unstemmed | Circulating Total Bilirubin and Future Risk of Hypertension in the General Population: The Prevention of Renal and Vascular End‐Stage Disease (PREVEND) Prospective Study and a Mendelian Randomization Approach |
title_short | Circulating Total Bilirubin and Future Risk of Hypertension in the General Population: The Prevention of Renal and Vascular End‐Stage Disease (PREVEND) Prospective Study and a Mendelian Randomization Approach |
title_sort | circulating total bilirubin and future risk of hypertension in the general population: the prevention of renal and vascular end‐stage disease (prevend) prospective study and a mendelian randomization approach |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721749/ https://www.ncbi.nlm.nih.gov/pubmed/29133521 http://dx.doi.org/10.1161/JAHA.117.006503 |
work_keys_str_mv | AT kunutsorsetork circulatingtotalbilirubinandfutureriskofhypertensioninthegeneralpopulationthepreventionofrenalandvascularendstagediseaseprevendprospectivestudyandamendelianrandomizationapproach AT kienekerlyannem circulatingtotalbilirubinandfutureriskofhypertensioninthegeneralpopulationthepreventionofrenalandvascularendstagediseaseprevendprospectivestudyandamendelianrandomizationapproach AT burgessstephen circulatingtotalbilirubinandfutureriskofhypertensioninthegeneralpopulationthepreventionofrenalandvascularendstagediseaseprevendprospectivestudyandamendelianrandomizationapproach AT bakkerstephanjl circulatingtotalbilirubinandfutureriskofhypertensioninthegeneralpopulationthepreventionofrenalandvascularendstagediseaseprevendprospectivestudyandamendelianrandomizationapproach AT dullaartrobinpf circulatingtotalbilirubinandfutureriskofhypertensioninthegeneralpopulationthepreventionofrenalandvascularendstagediseaseprevendprospectivestudyandamendelianrandomizationapproach |